Medical Research News

RSS

Consistent consumption of alcohol contributes to high blood pressure

High blood pressure is a leading cause of deaths in the world. Apart from millions with diagnosed hypertension, still many others are borderline hypertensive. High blood pressure increases the risk of a person to develop cardiovascular diseases, kidney problems, heart attack and even a stroke. One of the major contributors to high blood pressure is the consistent consumption of alcohol. Regular alcohol drinkers increase the risks of elevated blood pressure because it affects the normal functioning of the body by reversing what it needs to remain healthy.

28 May 2010

Overweight, obesity and low weight affect teenagers' physical fitness

This research was developed by Dr. Enrique Garcia Artero, from the Department of Physiology of the University of Granada, and coordinated by Professor Manuel J. Castillo Garzón. To carry out this project, the researcher used data from the national and European projects AVENA (Food and Assessment of Nutritional Status of Spanish Adolescents) and HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) and ALPHA (Assessing Levels of Physical Activity and Fitness; Public Health Executive Agency).

28 May 2010

Research finding could lead to first-ever target for drug therapy for lymphedema

A genetic mutation for inherited lymphedema associated with lymphatic function has been discovered that could help create new treatments for the condition, say researchers at the University of Pittsburgh Graduate School of Public Health. Their findings are reported in the June issue of the American Journal of Human Genetics.

28 May 2010

Good muscle mass, strength and diet needed to stave off diabetes

Sarcopenia - low skeletal muscle mass and strength - is often found in obese people and older adults; it has been hypothesized that sarcopenia puts individuals at risk for developing Type 2 diabetes.

28 May 2010

Roche launches GS Junior System benchtop DNA sequencing platform for life science research

Roche, announced today the global launch of the GS Junior System, the company's new benchtop next-generation DNA sequencing platform for life science research. The GS Junior System, developed by 454 Life Sciences, a Roche company, provides an integrated sequencing and bioinformatics solution, all in a size that is no bigger than a typical desktop laser printer.

From Roche Sequencing and Life Science 28 May 2010

AstraZeneca, NIDDK partnership to support Drug-Induced Liver Injury Network

A new public-private partnership between AstraZeneca and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will focus on supporting the work of the Drug-Induced Liver Injury Network (DILIN). DILIN is a group working to bring together essential scientific and financial resources to better understand drug-induce liver injury as well as effective screening, diagnostic and treatment options.

28 May 2010

Biomedical engineering professor receives Transition Career Development Award

Biomedical engineering professor David Zaharoff has been awarded a Transition Career Development Award by the National Cancer Institute to further his research on Interleukin-12, a powerful cytokine that shows great promise for therapeutic treatment of numerous types of cancer.

28 May 2010

Cardiac biomarkers help nephrologists manage fluid overload in dialysis patients: Study

Nephrologists must consider fluid overload effects when prescribing dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology. The fluid overload biomarker, N-terminal pro-brain-type natriuretic peptide, previously known as a "cardiac biomarker" in dialysis patients, is an important component of managing patients with kidney disease.

28 May 2010

New research links use of indoor tanning devices to increased risk of melanoma

New research from the University of Minnesota's School of Public Health and Masonic Cancer Center definitively links the use of indoor tanning devices to increased risk of melanoma, the most serious form of skin cancer.

28 May 2010

Fenwal biomedical engineer receives prestigious Junior Investigator Award for research on photopheresis

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that on Friday, May 29, 2010, the American Society for Apheresis will present Fenwal biomedical engineer Katherine Radwanski with the prestigious Junior Investigator Award for her research on photopheresis.

28 May 2010

E. coli O157:H7 is rare in some wildlife species of California's Central Coast region: Researchers

The disease-causing bacterium E. coli O157:H7 is present but rare in some wildlife species of California's agriculturally rich Central Coast region, an area often referred to as the nation's "salad bowl," reports a team or researchers led by a UC Davis scientist.

28 May 2010

Restricting salt intake helps control blood pressure in dialysis patients: Research

For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

28 May 2010

IPS Research joins SAFE-BioPharma Association

IPS Research Company, a major southwest clinical research investigator site located in Oklahoma City, OK, has joined SAFE-BioPharma Association and taken another step in the process of eliminating paper copies from its operations.

28 May 2010

New study examines internal and external uses of health outcomes data for promotional purposes

Health outcomes data can be an important promotional/commercial tool for the biopharma industry, but approaches differ company to company as the marketplace continues to evolve. A new study by Best Practices, LLC examines internal and external uses of health outcomes data for promotional purposes.

28 May 2010

Alcohol-related mortality increases in socioeconomically deprived areas of England and Wales

Researchers at the University of Sheffield have found that there are substantially increased death rates from alcohol-related diseases in socioeconomically deprived areas of England and Wales.

28 May 2010

The Wistar Institute Melanoma Research Center launched to develop new therapies for melanoma

In an effort to meet the rising rates of melanoma head-on, The Wistar Institute today announced the creation of The Wistar Institute Melanoma Research Center. The Center brings together scientists, physicians, the life sciences industry, and melanoma advocates in saving lives by advancing new and better therapies for this deadly disease.

28 May 2010

Individuals with poor oral hygiene at increased risk of heart disease

Individuals who have poor oral hygiene have an increased risk of heart disease compared to those who brush their teeth twice a day, finds research published today on BMJ.com.

28 May 2010

InNexus Biotechnology announces research Collaboration Agreement with National Cancer Institute

InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.

28 May 2010

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

Oregon Health & Science University is partnering with the University of Oregon and Harvard Medical School to expedite basic science research into new and existing drugs and compounds that may prevent the complications associated with Fanconi anemia, an inherited condition that can lead to bone marrow failure and cancer.

28 May 2010

Research finding may offer future alternative to antibiotics

A team of scientists from government, academia and private industry has developed a novel treatment that protects mice from infection with the bacterium that causes tularemia, a highly infectious disease of rodents, sometimes transmitted to people, and also known as rabbit fever. In additional experiments with human immune cells, the treatment also demonstrated protection against three other types of disease-causing bacteria that, like the tularemia bacteria, occur naturally, can be highly virulent, and are considered possible agents of bioterrorism.

28 May 2010

Medical Research News

Consistent consumption of alcohol contributes to high blood pressure

Overweight, obesity and low weight affect teenagers' physical fitness

Research finding could lead to first-ever target for drug therapy for lymphedema

Good muscle mass, strength and diet needed to stave off diabetes

Roche launches GS Junior System benchtop DNA sequencing platform for life science research

AstraZeneca, NIDDK partnership to support Drug-Induced Liver Injury Network

Biomedical engineering professor receives Transition Career Development Award

Cardiac biomarkers help nephrologists manage fluid overload in dialysis patients: Study

New research links use of indoor tanning devices to increased risk of melanoma

Fenwal biomedical engineer receives prestigious Junior Investigator Award for research on photopheresis

E. coli O157:H7 is rare in some wildlife species of California's Central Coast region: Researchers

Restricting salt intake helps control blood pressure in dialysis patients: Research

IPS Research joins SAFE-BioPharma Association

New study examines internal and external uses of health outcomes data for promotional purposes

Alcohol-related mortality increases in socioeconomically deprived areas of England and Wales

The Wistar Institute Melanoma Research Center launched to develop new therapies for melanoma

Individuals with poor oral hygiene at increased risk of heart disease

InNexus Biotechnology announces research Collaboration Agreement with National Cancer Institute

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

Research finding may offer future alternative to antibiotics

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News